Scott T. Nolan

704 total citations
7 papers, 550 citations indexed

About

Scott T. Nolan is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Scott T. Nolan has authored 7 papers receiving a total of 550 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 7 papers in Epidemiology and 2 papers in Molecular Biology. Recurrent topics in Scott T. Nolan's work include Tuberculosis Research and Epidemiology (7 papers), Mycobacterium research and diagnosis (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). Scott T. Nolan is often cited by papers focused on Tuberculosis Research and Epidemiology (7 papers), Mycobacterium research and diagnosis (6 papers) and Pneumocystis jirovecii pneumonia detection and treatment (2 papers). Scott T. Nolan collaborates with scholars based in United States and Netherlands. Scott T. Nolan's co-authors include Gyanu Lamichhane, William R. Bishai, Radhika Gupta, Nisheeth Agarwal, Frank Wolschendorf, Ying Wang, Randall J. Basaraba, Stefan H. Bossmann, Michael Niederweis and David F. Ackart and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Communications.

In The Last Decade

Scott T. Nolan

7 papers receiving 543 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Scott T. Nolan United States 7 305 219 202 122 57 7 550
Hélène Botella United States 11 338 1.1× 241 1.1× 214 1.1× 191 1.6× 95 1.7× 13 739
Gustavo Stadthagen France 10 283 0.9× 244 1.1× 375 1.9× 64 0.5× 107 1.9× 11 762
Avishek Mitra United States 10 249 0.8× 129 0.6× 118 0.6× 66 0.5× 35 0.6× 14 438
Alexander Speer Netherlands 16 581 1.9× 441 2.0× 356 1.8× 92 0.8× 100 1.8× 31 992
Jarukit E. Long United States 11 633 2.1× 483 2.2× 610 3.0× 103 0.8× 55 1.0× 15 1.1k
Michael V. Tullius United States 16 414 1.4× 322 1.5× 501 2.5× 26 0.2× 170 3.0× 19 1.0k
Mélanie A. C. Ikeh United States 11 290 1.0× 178 0.8× 192 1.0× 26 0.2× 51 0.9× 16 555
Beatrice Saviola United States 11 206 0.7× 179 0.8× 232 1.1× 23 0.2× 54 0.9× 19 533
Yuriko Ozeki Japan 18 431 1.4× 441 2.0× 214 1.1× 31 0.3× 172 3.0× 44 786
Magdalena M. van der Kooi‐Pol Netherlands 10 169 0.6× 104 0.5× 169 0.8× 67 0.5× 34 0.6× 10 432

Countries citing papers authored by Scott T. Nolan

Since Specialization
Citations

This map shows the geographic impact of Scott T. Nolan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott T. Nolan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott T. Nolan more than expected).

Fields of papers citing papers by Scott T. Nolan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott T. Nolan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott T. Nolan. The network helps show where Scott T. Nolan may publish in the future.

Co-authorship network of co-authors of Scott T. Nolan

This figure shows the co-authorship network connecting the top 25 collaborators of Scott T. Nolan. A scholar is included among the top collaborators of Scott T. Nolan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott T. Nolan. Scott T. Nolan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Nolan, Scott T., et al.. (2015). Immunogenicity without Efficacy of an Adenoviral Tuberculosis Vaccine in a Stringent Mouse Model for Immunotherapy during Treatment. PLoS ONE. 10(5). e0127907–e0127907. 7 indexed citations
2.
Lee, Jong‐Hee, Nicole C. Ammerman, Scott T. Nolan, et al.. (2012). Isoniazid resistance without a loss of fitness in Mycobacterium tuberculosis. Nature Communications. 3(1). 753–753. 29 indexed citations
3.
Lamichhane, Gyanu, et al.. (2011). Essential Metabolites of Mycobacterium tuberculosis and Their Mimics. mBio. 2(1). e00301–10. 51 indexed citations
4.
Wolschendorf, Frank, David F. Ackart, Tej B. Shrestha, et al.. (2011). Copper resistance is essential for virulence of Mycobacterium tuberculosis. Proceedings of the National Academy of Sciences. 108(4). 1621–1626. 263 indexed citations
5.
Nolan, Scott T. & Gyanu Lamichhane. (2010). Protective Efficacy of BCG Overexpressing an L,D-Transpeptidase against M. tuberculosis Infection. PLoS ONE. 5(10). e13773–e13773. 10 indexed citations
6.
Converse, Paul J., Kathleen D. Eisenach, Sue A. Theus, et al.. (2010). The Impact of Mouse Passaging of Mycobacterium tuberculosis Strains prior to Virulence Testing in the Mouse and Guinea Pig Aerosol Models. PLoS ONE. 5(4). e10289–e10289. 12 indexed citations
7.
Agarwal, Nisheeth, Gyanu Lamichhane, Radhika Gupta, Scott T. Nolan, & William R. Bishai. (2009). Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase. Nature. 460(7251). 98–102. 178 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026